Globeflex Capital L P Cooper Companies, Inc. Transaction History

Globeflex Capital L P

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$280.08 - $347.78 $572,483 - $710,862	-2,044 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$270.93 - $320.3 $195,340 - $230,936	-721 Reduced 26.08%	2,044 $580,000
Q1 2020 May 13, 2020	BUY	$243.44 - $359.98 $55,260 - $81,715	227 Added 8.94%	2,765 $762,000
Q3 2019 Nov 13, 2019	BUY	$294.25 - $341.49 $95,337 - $110,642	324 Added 14.63%	2,538 $754,000
Q2 2019 Aug 12, 2019	BUY	$279.29 - $336.89 $618,348 - $745,874	2,214 New	2,214 $746,000

1.23M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.62B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

Stay updated on Globeflex Capital L P with notifications on news.